Bereket Mochona to Humans
This is a "connection" page, showing publications Bereket Mochona has written about Humans.
Connection Strength
0.149
-
Mochona B, Redda KK, Offringa IA, Allen J, Carpten JD, Stern MC, Reams RR, Wilkie DJ. Mentoring Minority Cancer Researchers of Tomorrow: Comparison of the Face-to-Face, Virtual, and Hybrid Training Methods of the CaRE2 Summer Cancer Research Education and Training Program. J Cancer Educ. 2024 Aug; 39(4):405-412.
Score: 0.045
-
Mochona B, Lyon D, Offringa IA, Redda KK, Reams RR, Odedina F, Wilkie DJ, Stern MC, Carpten JD. Developing a Novel Framework for an Undergraduate Cancer Research Education and Engagement Program for Underrepresented Minority Students: the Florida-California CaRE2 Research Education Core (REC) Training Program. J Cancer Educ. 2021 10; 36(5):914-919.
Score: 0.038
-
Mochona B, Qi X, Euynni S, Sikazwi D, Mateeva N, Soliman KF. Design and evaluation of novel oxadiazole derivatives as potential prostate cancer agents. Bioorg Med Chem Lett. 2016 06 15; 26(12):2847-2851.
Score: 0.026
-
Adinew GM, Messeha S, Taka E, Mochona B, Redda KK, Soliman KFA. Thymoquinone Inhibition of Chemokines in TNF-a-Induced Inflammatory and Metastatic Effects in Triple-Negative Breast Cancer Cells. Int J Mol Sci. 2023 Jun 08; 24(12).
Score: 0.011
-
Reams RR, Odedina FT, Carpten JD, Redda K, Stern MC, Krieger JL, Aparicio J, Hensel B, Askins N, Abreu A, Adams A, Agyare E, Ali J, Allen JM, Al? R, Baezconde-Garbanati L, Brant J, Brown CP, Buxbaum SG, Cohen P, Cozen W, Ezenwa MO, Falzarano S, Fillingim RB, Flores-Rozas H, Fredenburg KM, George T, Han B, Huang Y, Hughes Halbert C, Kiros GE, Lamango NS, Lee JH, Lyon DE, Mitchell DA, Mochona B, Nieva JJ, Offringa IA, Okunieff P, Parker A, Rhie SK, Richey JM, Rogers SC, Salhia B, Schmittgen TD, Segal R, Setiawan VW, Smith U, Su LM, Suther S, Trevino J, Velazquez-Villarreal EI, Webb FJ, Wu AH, Yao Y, Wilkie DJ. Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center: Structure, Innovations, and Initial Outcomes. Cancer Control. 2023 Jan-Dec; 30:10732748231197878.
Score: 0.010
-
Odedina FT, Behar-Horenstein LS, Fathi P, Kaninjing E, Nguyen J, Askins N, Reams RR, Mochona B, Ezeani A, Lyon D, Jacobs K, Maduka M. Improving Representation of Underrepresented Minority (URM) Students in Oncology Biomedical Research Workforce: Outcome Evaluation from the ReTOOL Program. J Cancer Educ. 2022 02; 37(1):37-45.
Score: 0.010
-
Adinew GM, Taka E, Mochona B, Badisa RB, Mazzio EA, Elhag R, Soliman KFA. Therapeutic Potential of Thymoquinone in Triple-Negative Breast Cancer Prevention and Progression through the Modulation of the Tumor Microenvironment. Nutrients. 2021 Dec 25; 14(1).
Score: 0.010